Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 4,243 | 4,140 | 3,856 | 3,074 | 2,401 |
| Cost of Goods | 2,824 | 2,617 | 2,457 | 2,089 | 1,652 |
| Gross Profit | 1,419 | 1,523 | 1,399 | 985 | 749 |
| Operating Expenses | 3,347 | 2,787 | 3,498 | 2,913 | 2,116 |
| Operating Income | -1,104 | -647 | -1,641 | -1,839 | -715 |
| Interest Expense | 100 | 12 | 12 | -12 | -2 |
| Other Income | -24 | 0 | 0 | -21 | -11 |
| Pre-tax Income | -1,227 | -660 | -1,653 | -1,848 | -724 |
| Net Income Continuous | -1,227 | -660 | -1,653 | -1,848 | -724 |
| Net Income | $-1,227 | $-660 | $-1,653 | $-1,848 | $-724 |
| EPS Basic Total Ops | 0.00 | -0.03 | -0.06 | -0.06 | 0.00 |
| EPS Basic Continuous Ops | -0.03 | -0.02 | -0.05 | -0.05 | -0.02 |
| EPS Diluted Total Ops | 0.00 | -0.03 | -0.06 | -0.06 | 0.00 |
| EPS Diluted Continuous Ops | -0.03 | -0.02 | -0.05 | -0.05 | -0.02 |
| EBITDA(a) | $-1,056 | $-583 | $-1,577 | $-1,802 | $-662 |